Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...

Researchers have found a new way to reduce the effects of pre-eclampsia using mRNA-lipid nanoparticle therapies.

The lipid nanoparticles (LNP) market is witnessing strong growth, fueled by advancements in RNA-based therapies, gene therapy, and targeted drug delivery systems. Thus, their stability and ...

Research papers focused on the importance of LNP structures and injection route in developing better LNP non-viral gene therapies for autoimmune diseases and metabolic disorders, such as diabetes.

Efforts to design new ionizable lipids aim to reduce immune responses and improve the efficiency of drug release within cells. Automating production processes is another focus to meet the increasing ...

Averna Therapeutics, Inc. ("Averna"; formerly known as Exsilio Therapeutics, Inc.), a biotechnology company developing ...

Research papers focused on the importance of LNP structures and injection route in developing better LNP non-viral gene therapies for autoimmune diseases and metabolic disorders, such as diabetes. The ...